AzTrials
AzTrials

DementiaBWIBS-WMNCT07673770

Brain Wave Informed Non-invasive Brain Stimulation: Improving Neural Networks of Working Memory in Dementia: a Proof-of-concept Study

A study testing EEG-triggered TMS in people with Dementia and Alzheimer s Disease, run by McMaster University at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Working memory helps us hold information for a short time so one can think and make decisions. It keeps thoughts on track. As one gets older, working memory gets weaker. In people with dementia, it gets much worse, making it harder to talk with others, follow directions, or remember things like shopping lists. Read more about this study

Who is it for?
Ages 55 years and older
Conditions the study is for
Dementia, Alzheimer s Disease
What is being tested?
EEG-triggered TMS
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteCanada
Study dates
7 Jul 2026to 1 Aug 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals must be diagnosed with Alzheimer's Disease or related dementias by a clinician.
  • Individuals must exhibit adequate oral communication skills and cognitive function sufficient to obtain a score above 10 on the MMSE
  • Instructions will be delivered in English; therefore participants must demonstrate an understanding of instruction provided in English.
  • Individuals must be at least 55 years or older

Who cannot join

  • Contraindications to TMS; presence of a pacemaker, metal/electrical/magnetic implants not including titanium, known history of untreated or uncontrolled psychological disorders, pregnancy, history of seizure or diagnoses of epilepsy, are taking any prescription medications that increase the risk of seizure.
  • Allergy to rubbing alcohol, which is needed to prepare electromyography for TMS

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Canada1 site, 1 recruiting
  • Ivor Wynne Center

    Hamilton, Ontario, L8S 4L8

    Aimee Nleson, PhD, 9055259140 Ext. 28053, nelsonaj@mcmaster.ca

    Recruiting

Other trials in Canada

About this study

Working memory helps us hold information for a short time so one can think and make decisions. It keeps thoughts on track. As one gets older, working memory gets weaker. In people with dementia, it gets much worse, making it harder to talk with others, follow directions, or remember things like shopping lists.

This may happen because brain waves that support working memory fall out of sync. Researchers can see these brain waves using a test called EEG. In this study, the investigators will try to get these brain waves back in sync using a safe, non-invasive form of brain stimulation called transcranial magnetic stimulation (TMS), and will time it to each person's brain waves to make it more effective. The goal is to improve working memory in people with dementia. If successful, dementia patients may be able to be more independent taking pressure off their families.

Read the detailed description

Dementia is cognitive decline severe enough to interfere with daily function and is more severe than cognitive decline normally occurring as a result of aging. Two major cognitive domains which are typically impaired in dementia include executive function and learning/memory. Impairments in executive function interfere with an individual's ability to plan, organize, and switch between tasks, with impairments in this domain significantly reducing an individual's ability to perform activities of daily living (ADL). In the learning/memory domain, episodic memory and working memory are altered. Impairments in episodic memory lead to individuals being unable to recall past events or experiences, as well as being unable to learn and retain details about new experiences. Impairments in working memory lead to individuals being unable to retain information for short periods of time during the execution of a task, such as remembering what was said earlier in a conversation or remembering a set of instructions while executing them. Similar to executive function, decline in episodic and/or working memory is related to reduced ADL. Lower ADL in patients with dementia is associated with higher burden on their caregivers. Dementia caregivers in Canada provide over 580 million hours of care annually. Dementia produces a ripple effect for all Canadians through hospital stays and emergency department visits, loss of productivity from absenteeism, presenteeism, and early retirement of caregivers leading to an overall annual economic burden of over $10 billion CAD. At present, there is no gold standard treatment for reducing cognitive impairment in dementia.

While dementia is thought to be a result of a combination of structural and chemical changes in the brain, recent work has highlighted the interaction between these changes and how the brain functionally adapts to them. The 2024 Lancet Neurology Commission on dementia highlights some individuals may have the chemical and structural brain changes associated with dementia, but do not suffer cognitive decline beyond what is associated with normal aging. More specifically, a community-based autopsy study of 4,354 individuals over the age of 80 in the United Kingdom measured the number of neuropathologies including severe neuritic plaques, neurofibrillary tangles, micro \& macroinfarcts, and Lewy bodies, found that 51% of individuals with two or more significant neuropathologies did not have a clinical diagnosis of dementia. The brain's ability to withstand neuropathology without leading to cognitive decline is defined as cognitive reserve. Cognitive reserve is thought to allow recruitment of brain networks typically used for other functions or more efficient use of existing brain networks. On a neurophysiological level, it is thought that individuals with higher cognitive reserve generally have higher resting state functional connectivity between regions involved in cognition. Thus, increasing functional connectivity between brain regions involved in cognitive domains impaired in dementia may be able to improve cognitive reserve, reducing cognitive impairment in dementia.

Electroencephalography (EEG) is an effective method for measuring functional connectivity between brain regions non-invasively. EEG functional connectivity associated with proper functioning of cognitive domains impaired in dementia may provide a target biomarker to improve cognitive reserve. While EEG functional connectivity during executive function and episodic memory have been measured, there is a large degree of overlap in functional connectivity changes between executive function and working memory, likely due to both sharing some cognitive processes. Further, there are multiple studies demonstrating the causal role of EEG functional connectivity measures in working memory. Thus, EEG functional connectivity associated with working memory may provide a more promising biomarker to target for cognitive reserve.

EEG functional connectivity is a measure of the synchrony between EEG waves from two different brain regions. During successful working memory maintenance, the level of synchrony in the theta band between the frontal and temporal cortex has been shown to increase in healthy adults. Frontotemporal theta band synchrony is most commonly measured through phase-locking value (PLV). High PLV is thought to indicate stronger communication between cortices. Further, temporarily enhancing frontotemporal theta PLV using non-invasive brain stimulation known as transcranial alternating current stimulation (tACS) has been shown to restore working memory performance in older adults to the level of healthy young adults. Additionally, a metanalysis of 28 placebo-controlled studies determining the effects of different tACS protocols on working memory, found that only two forms of tACS improved working memory performance: frontotemporal theta and occipitoparietal gamma. Occipitoparietal gamma was thought to improve working memory performance as a result of many of the included studies using visual based working memory tasks. Nonetheless, these findings provide strong evidence for the role of frontotemporal theta PLV in working memory and highlight the potential for improving cognition by improving frontotemporal theta PLV long-term. At present, tACS is the only approach that can effectively improve PLV between two brain regions. However, its effects are typically temporary, lasting between 30min-70min after stimulation. Thus, enhancing PLV between two brain regions long-term may potentially produce lasting improvements in cognition in dementia.

High PLV is thought to occur due to strong synapses between two populations of neurons being recorded via EEG. If the strength of the synapses between these two populations were increased, then, theoretically their PLV would likely also increase. In the context of working memory, strengthening the synapses between neurons in the frontal and temporal cortex that generally contribute to the EEG theta band may result in a significant increase in frontotemporal theta PLV on EEG. These synapses can potentially be strengthened through a form of neuroplasticity known as long-term potentiation (LTP). LTP can potentially be induced through spike-timing dependent plasticity. Spike-timing dependent plasticity occurs through co-incident firing of the sending and receiving neurons. Considering that the frontal cortex is largely considered to be the hub for most cognitive functions, it is suggested that the frontal cortex projects onto the temporal cortex. Therefore, stimulating the frontal cortex when neurons in the temporal cortex contributing to the theta band are most likely to fire action potentials, through spike-timing dependent plasticity, may result in theta band specific LTP between the frontal and temporal cortex, in turn producing long-term enhancements in frontotemporal theta PLV.

The probability that a population of neurons will fire an action potential has previously been shown to be related to the phase of the EEG band. More specifically, non-invasive brain stimulation known as transcranial magnetic stimulation (TMS), synchronized to mu (8-13Hz) troughs results in significantly greater muscle activity than peaks or random phases. This is thought to be a result of the cortex being more excitable at troughs than any other phase. Therefore, triggering TMS over the frontal cortex at temporal cortex theta troughs, while accounting for conduction delay between the two cortices, may induce EEG theta band specific LTP between the two cortices. This approach has not been used in healthy adults or in clinical populations including Alzheimer's disease and related dementias.

The goal of this study open-label proof-of-concept study is to determine the feasibility and potential efficacy of the approach of temporal cortex theta trough triggered frontal TMS. This study will inform the design of a powered study to observe effects of EEG-TMS on working memory and will inform future work to identify and target biomarkers of other impacted cognitive domains in dementia. This study also aims to determine the potential of this technique to produce long-term improvements in working memory \& cognition in individuals suffering from dementia as well as improvements in frontotemporal theta PLV.

By improving working memory in dementia, overall cognition may be improved, dementia patients' ADL may increase, and strain on their caregivers may be reduced. This study paves the way for future work that aims to improve the cognitive domains impaired in dementia by targeting the neurophysiological biomarkers of good function in those domains. Overall, this work may provide significant benefit to individuals suffering from dementia through potentially improved cognition and independence, while also providing long-term benefits for future research aiming to improve cognition in dementia.

Being tested
EEG-triggered TMS
Keywords
Dementia, Alzheimer's Disease, transcranial magnetic stimulation, eeg, electroencephalography
Medical subject headings
Dementia, Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EEG-triggered TMSDevice

    This intervention involves delivering transcranial magnetic stimulation (TMS) to the dorsolateral prefrontal cortex (dlPFC) during working memory maintence timed to a specific electroencephalography (EEG) phase from the temporal cortex. The intervention is attempting to facilitate improved communication between the dlPFC and temporal cortex to improve working memory in people living with dementia.

Study groups in NCT07673770
Study groupRoleWhat they receive
Intervention: EEG-triggered TMSExperimentalThe electroencephalography (EEG) triggered transcranial magnetic stimulation (TMS) arm involves receiving TMS timed to particular phases of EEG involved in working memory. TMS involves the delivery of brief current to the part of the brain that is involved in working memory. EEG involves placing 32 electrodes on the surface of then head and reading the brain's waves in real-time. TMS will be delivered to the part of the brain involved in working memory timed to EEG recorded brain waves
Receives: Device: EEG-triggered TMS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Forward digit span

    A set of numbers will be presented one after another and you will be asked to recall them in the same order after a brief maintence period. Accuracy and reaction time will be measured

    Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.

  2. Reverse digit span

    A set of digits will be presented and you must recall the digits in reverse order. Accuracy and reaction time will be measured

    Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.

  3. Sentence span

    You will be presented with a set of sentences one after another. You are tasked with remembering the last word of each sentence. Then after a brief maintence period, you will be asked to repeat the last word of each sentence in the order the sentences were presented in. Accuracy and reaction time will be measured

    Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.

  4. Grocery list task

    You will be presented with a set of grocery items one after another. After a brief maintence period, you will be asked to repeat the items in the same order they were presented in. Accuracy and reaction time will be measured

    Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.

  5. Montreal Cognitive Assessment (MoCA) score

    The MOCA is a tool used to assess cognitive impairment. It assesses various aspects of cognition including executive function, memory, language, attention, and orientation. A score less than 25 out of 30 is considered significant for MCI.

    Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.

  6. Mini-Mental State Examination (MMSE) scores

    The MMSE is a 30 point cognitive assessment that involves a variety of cognitive tasks to assess an individual's cognitive abilities. It takes 5-10 minutes to complete.

    Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.

Secondary outcomes (2)
  1. Frontotemporal EEG connectivity (imaginary component of coherence)

    The investigators will measure changes in the level of connectivity between the frontal and temporal cortex during working memory through electroencephalography (EEG). This metric indicates the level of communication between brain areas.

    Measured: Recorded before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.

  2. Prefrontal theta-gamma coupling (modulation index)

    Theta-gamma coupling in the prefrontal cortex (involved in coordinating the order of items stored in working memory) during working memory will be extracted from electroencephalography (EEG) recorded during working memory maintenance.

    Measured: Before the intervention, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2026
  2. Study start7 Jul 2026 (estimated)
  3. Primary completion1 Apr 2028 (estimated)
  4. Study completion1 Aug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Proof-of-concept open-label study where all participants will receive intervention
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07673770
Sponsor's protocol ID
19029
Acronym
BWIBS-WM
Status last verified
Jul 2026
First submitted
10 Apr 2026
Last updated
7 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Albert, M. S. (2011). Changes in Cognition. Neurobiology of Aging, 32(0 1), S58-S63. https://doi.org/10.1016/j.neurobiolaging.2011.09.010 Alzheimer Society of Canada. (2022, September 6). Navigating the Path Forward for Dementia in Canada: The Landmark Study Report #1. Alzheimer Society of Canada. https://alzheimer.ca/en/research/reports-dementia/navigating-path-forward-landmark-report-1 Barbey, A. K., Koenigs, M., & Grafman, J. (2013). Dorsolateral Prefrontal Contributions to Human Working Memory. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 49(5), 1195-1205. https://doi.org/10.1016/j.cortex.2012.05.022 Bastos, A. M., & Schoffelen, J.-M. (2016). A Tutorial Review of Functional Connectivity Analysis Methods and Their Interpretational Pitfalls. Frontiers in Systems Neuroscience, 9. https://doi.org/10.3389/fnsys.2015.00175 Casarotto, S., Fecchio, M., Rosanova, M., Varone, G., D'Ambrosio, S., Sarasso, S., Pigorini, A., Russo, S., Comanducci, A., Ilmoniemi, R. J., & Massimini, M. (2022). The rt-TEP tool: Real-time visualization of TMS-Evoked Potentials to maximize cortical activation and minimize artifacts. Journal of Neuroscience Methods, 370, 109486. https://doi.org/10.1016/j.jneumeth.2022.109486 Daume, J., Gruber, T., Engel, A. K., & Friese, U. (2017). Phase-Amplitude Coupling and Long-Range Phase Synchronization Reveal Frontotemporal Interactions during Visual Working Memory. The Journal of Neuroscience, 37(2), 313. https://doi.org/10.1523/JNEUROSCI.2130-16.2016 Eldridge, S. M., Lancaster, G. A., Campbell, M. J., Thabane, L., Hopewell, S., Coleman, C. L., & Bond, C. M. (2016). Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework. PloS One, 11(3), e0150205. https://doi.org/10.1371/journal.pone.0150205 Fox, M. D., Buckner, R. L., White, M. P., Greicius, M. D., & Pascual-Leone, A. (2012). Efficacy of TMS targets for depression is related to intrinsic functional connec

Questions about this trial

What is this clinical trial studying?

A study testing EEG-triggered TMS in people with Dementia and Alzheimer s Disease, run by McMaster University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aimee Nelson ((905) 525-9140 ext. 28053, nelsonaj@mcmaster.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Forward digit span (time frame: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07673770, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in